Precipio Net Profit Margin 2010-2024 | PRPO

Precipio net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Precipio Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-12-31 $0.02B $0.00B -23.53%
2024-09-30 $0.02B $0.00B -18.75%
2024-06-30 $0.02B $0.00B -18.75%
2024-03-31 $0.02B $0.00B -25.00%
2023-12-31 $0.02B $-0.01B -31.25%
2023-09-30 $0.01B $-0.01B -57.14%
2023-06-30 $0.01B $-0.01B -90.91%
2023-03-31 $0.01B $-0.01B -111.11%
2022-12-31 $0.01B $-0.01B -150.00%
2022-09-30 $0.01B $-0.01B -150.00%
2022-06-30 $0.01B $-0.01B -137.50%
2022-03-31 $0.01B $-0.01B -150.00%
2021-12-31 $0.01B $-0.01B -100.00%
2021-09-30 $0.01B $-0.01B -100.00%
2021-06-30 $0.01B $-0.01B -112.50%
2021-03-31 $0.01B $-0.01B -114.29%
2020-12-31 $0.01B $-0.01B -233.33%
2020-09-30 $0.01B $-0.02B -320.00%
2020-06-30 $0.00B $-0.02B -375.00%
2020-03-31 $0.00B $-0.02B -475.00%
2019-12-31 $0.00B $-0.01B -350.00%
2019-09-30 $0.00B $-0.02B -425.00%
2019-06-30 $0.00B $-0.02B -475.00%
2019-03-31 $0.00B $-0.02B -400.00%
2018-12-31 $0.00B $-0.02B -500.00%
2018-09-30 $0.00B $-0.03B -650.00%
2018-06-30 $0.00B $-0.03B -1066.67%
2018-03-31 $0.00B $-0.04B -1900.00%
2017-12-31 $0.00B $-0.03B -3300.00%
2017-09-30 $0.00B $-0.02B -1900.00%
2017-06-30 $0.00B $-0.01B -900.00%
2017-03-31 $0.00B 0 0.00%
2016-12-31 $0.00B $0.00B -150.00%
2016-09-30 $0.00B $-0.02B -2400.00%
2016-06-30 $0.00B $-0.03B -3200.00%
2016-03-31 $0.00B $-0.04B 0.00%
2015-12-31 $0.00B $-0.03B -3400.00%
2015-09-30 $-0.02B $-0.02B 133.33%
2015-06-30 $-0.01B $-0.01B 109.09%
2015-03-31 $0.00B $-0.01B 325.00%
2014-12-31 $0.00B $-0.01B -1400.00%
2014-09-30 $0.02B $-0.01B -52.17%
2014-06-30 $0.03B $-0.02B -69.23%
2014-03-31 $0.03B $-0.02B -65.38%
2013-12-31 $0.03B $-0.02B -62.96%
2013-09-30 $0.03B $-0.02B -53.57%
2013-06-30 $0.03B $-0.01B -41.38%
2013-03-31 $0.03B $-0.01B -32.26%
2012-12-31 $0.03B $-0.01B -29.03%
2012-09-30 $0.03B $-0.01B -21.21%
2012-06-30 $0.03B $-0.01B -18.18%
2012-03-31 $0.03B $-0.01B -34.38%
2011-12-31 $0.03B $-0.01B -34.38%
2011-09-30 $0.03B $-0.01B -42.86%
2011-06-30 $0.02B $-0.01B -45.83%
2011-03-31 $0.02B $-0.01B -28.57%
2010-12-31 $0.02B $0.00B -15.79%
2010-09-30 $0.02B $0.00B -9.52%
2010-06-30 $0.02B $0.00B -4.55%
2010-03-31 $0.02B $0.00B -4.55%
2009-12-31 $0.02B $0.00B -9.09%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.010B $0.019B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.774B 53.56
Hims & Hers Health (HIMS) United States $11.630B 121.74
Tempus AI (TEM) United States $10.119B 0.00
Inspire Medical Systems (INSP) United States $4.616B 72.12
IRhythm Technologies (IRTC) United States $4.348B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $1.955B 12.10
Clover Health Investments (CLOV) United States $1.926B 0.00
Schrodinger (SDGR) United States $1.732B 0.00
Phreesia (PHR) United States $1.434B 0.00
Azenta (AZTA) United States $1.154B 53.74
Omnicell (OMCL) United States $1.154B 20.35
10x Genomics (TXG) United States $1.016B 0.00
Fulgent Genetics (FLGT) United States $0.568B 0.00
Butterfly Network (BFLY) United States $0.530B 0.00
Talkspace (TALK) United States $0.512B 152.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.381B 850.00
Claritev (CTEV) United States $0.344B 0.00
Health Catalyst (HCAT) United States $0.279B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.148B 0.00
American Well (AMWL) United States $0.106B 0.00
Retrieve Medical Holdings (RMHI) United States $0.094B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.03
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
P3 Health Partners (PIII) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00